ARCHIVES

Sponsors Withdraw Indications for Iressa, Celebrex

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

Avastin Increases Overall Survival 3.7 Months

February 22, 2013

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000

NCI, NHGRI Fund Two More Components of TCGA Project.

October 27, 2006